No Data
No Data
Evercore Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Raises Target Price to $60
Analysts' Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)
J.P. Morgan Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)
Major Stakeholder Sells Millions in BridgeBio Pharma Stock!
Sector Update: Health Care Stocks Retreat Thursday Afternoon
Cantor Fitzgerald Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $95
SteadyBoomBeepBeep : wow you’re the only one here